Form 8-K - Current report:
SEC Accession No. 0001641172-25-001125
Filing Date
2025-03-28
Accepted
2025-03-28 14:17:28
Documents
16
Period of Report
2025-03-25
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50954
2 ex10-1.htm EX-10.1 34601
  Complete submission text file 0001641172-25-001125.txt   324123

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ftii-20250325.xsd EX-101.SCH 4238
4 XBRL DEFINITION FILE ftii-20250325_def.xml EX-101.DEF 27361
5 XBRL LABEL FILE ftii-20250325_lab.xml EX-101.LAB 37954
6 XBRL PRESENTATION FILE ftii-20250325_pre.xml EX-101.PRE 25981
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7456
Mailing Address 128 GAIL DRIVE NEW ROCHELLE NY 10805
Business Address 128 GAIL DRIVE NEW ROCHELLE NY 10805 9143164805
FutureTech II Acquisition Corp. (Filer) CIK: 0001889450 (see all company filings)

EIN.: 872551539 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41289 | Film No.: 25784527
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)